ADAGE CAPITAL PARTNERS GP, L.L.C. – Alnylam Pharmaceuticals, Inc. Transaction History
ADAGE CAPITAL PARTNERS GP, L.L.C. portfolio value:
$97.07M
portfolio value
ADAGE CAPITAL PARTNERS GP, L.L.C. quarter portfolio value change:
+37.24%
quarter
Alnylam Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +185.29% | 315K shares | 72.28M | $200.16 | 485K |
| Q2 2022 | share | Increase | +135.13% | 97.7K shares | 12.98M | $145.85 | 170K |
| Q1 2022 | share | Decrease | -45.35% | -60K shares | -10.62M | $163.29 | 72.3K |
| Q4 2021 | share | Increase | 0.00% | 132.3K shares | 22.43M | $171.03 | 132.3K |
| Q2 2018 | share | Decrease | -100.00% | -240K shares | -28.58M | $98.49 | 0 |
| Q1 2018 | share | Decrease | -17.24% | -50K shares | -8.26M | $119.1 | 240K |
| Q4 2017 | share | Increase | 0.00% | 290K shares | 36.84M | $127.05 | 290K |